Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 209-548-7 | CAS number: 585-07-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
GPMT (Magnusson and Kligman), GLP not specified, reliability 2: not sensitizing
FCAT, GLP not specified, reliability 2: not sensitizing
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Version / remarks:
- 1992
- Deviations:
- yes
- Remarks:
- No information regarding a reliability check of the test procedure; choice of the vehicle and justification for its usage not given; negative control data are not presented
- Principles of method if other than guideline:
- GPMT according to Magnusson and Kligman 1970
- GLP compliance:
- not specified
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- The Guinea Pig Maximization Test (GPMT) has been carried out as an animal test to predict human sensitization for over a decade and is recommended by international test guidelines such as OECD. The available data do not justify conducting an additional LLNA due to animal welfare.
- Specific details on test material used for the study:
- - Source: Polyscience Inc., Warrington, USA
- Purity: > 99% - Species:
- guinea pig
- Strain:
- other: Himalayan white spotted outbred strain
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Inst. for Biomedical Research, Füllinsdorf, CH
- Weight at study initiation: 350 - 450 g
- Housing: in pairs
- Diet (e.g. ad libitum): pellet diet containing vitamin C - Route:
- intradermal
- Vehicle:
- peanut oil
- Concentration / amount:
- 0.5 M/ 0.1 mL
- Day(s)/duration:
- day 0/ single injection
- Adequacy of induction:
- not specified
- Route:
- epicutaneous, occlusive
- Vehicle:
- other: 80 % ethanol
- Concentration / amount:
- 1 M/ 1 mL
- Day(s)/duration:
- day 7-9
- Adequacy of induction:
- highest concentration used causing mild-to-moderate skin irritation and well-tolerated systemically
- No.:
- #1
- Route:
- epicutaneous, occlusive
- Vehicle:
- other: unclear: pet., peanut oil or Aramek
- Concentration / amount:
- highest non-irritant concentration and 2 lower concentrations (not further specified)/ 0.025 mL
- Day(s)/duration:
- day 21-22
- Adequacy of challenge:
- highest non-irritant concentration
- No.:
- #2
- Route:
- epicutaneous, open
- Vehicle:
- other: unclear: pet., peanut oil or Aramek
- Concentration / amount:
- highest non-irritant concentration and 2 lower concentrations (not further specified)/ 0.025 mL
- Day(s)/duration:
- day 35
- Adequacy of challenge:
- highest non-irritant concentration
- No. of animals per dose:
- 10 (control 6)
- Details on study design:
- MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 2
- Exposure period: up to 7 days
- Test groups: 3 pairs of intradermal injections (day 0): 1: FCA alone, 2: test material in vehicle, 3; test material in FCA; epicutaneous application (day 7)
- Control group: These animals received the same treatment without the test material
- Site: shoulder region, the injections with FCA and the test material in vehicle were close to each other and nearest to he head; the injection with FCA and the test material was caudally
- Frequency of applications: 3 injections, 1 epicutaneous application
- Duration: day 0- day 9
- Concentrations: 0.5 M (intradermal), 1 M (epicuateneous)
B. CHALLENGE EXPOSURE
- No. of exposures: 2
- Day(s) of challenge: day 21 and day 35
- Exposure period: 24 h (occlusive treatment)
- Test groups: epicutaneous application occlusive and open
- Control group: these animals received the same treatment; in addition the vehicle was tested alone
- Site: right flank (day 21), left flank (day 35)
- Concentrations: highest non-irritant concentration and two lower concentrations (not further specified)
- Evaluation (hr after challenge): 1st and 2nd challenge: 48 and 72 h
other: The maximum non-irritant concentration was determined in a pre-test. The used vehicle was Aramek (oleum arachidis/methylethylketone). Progressively dilutions of the test material were investigated after 24 and 48 h after single open application the clipped flank of 8 animals. - Challenge controls:
- 6 animals
- Positive control substance(s):
- no
- Positive control results:
- not included
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- highest non-irritant concentration and two lower concentrations
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- no data
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- 2nd reading
- Hours after challenge:
- 72
- Group:
- test chemical
- Dose level:
- highest non-irritant concentration and two lower concentrations
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- no data
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- rechallenge
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- highest non-irritant concentration and two lower concentrations
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- no data
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- rechallenge
- Hours after challenge:
- 72
- Group:
- test chemical
- Dose level:
- highest non-irritant concentration and two lower concentrations
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- no data
- Remarks on result:
- no indication of skin sensitisation
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The test substance was not sensitizing under the conditions of the present study in guinea pigs.
- Executive summary:
A publication is available which asesses the potential of the test substance to induce delayed contact hypersensitivity using the guinea pig maximization test (GPMT) based on the method of Magnusson and Kligman in a non-GLP conform study.
The concentrations of the test substance suitable for use in the main experiment were determined in a pretest. The minimum irritant concentration was determined in FCA pretreated animals. The maximum non-irritant concentration also was determined. The used vehicle in the pre-test was Aramek (oleum arachidis/methylethylketone). For the intradermal induction on day 0, 3 pairs of injections were set on the clipped shoulder region. One injection was with FCA alone, the second injection was the test material (0.5 M) in vehicle (peanut oil), the third injection was the test material (0.5 M) in FCA. On day 7, an epicutaneous induction with 1 M test material in the vehicle (80% ethanol) (the concentration giving a slight to moderate irritation) was performed on the same shoulder region. The challenge was performed on day 21 (epicutaneous, occlusive) and day 35 (epicutaneous, open) thereafter. The highest concentration tested was the maximum non-irritating concentration. In addition two lower concentrations and the vehicle were tested. The results were graded according to the classification of Magnusson & Kligman. Both challenges exhibited no positive reactions (0/10 animals).
Based on the results of this study it was concluded that t-butyl methacrylate does not have a sensitizing effect on the skin of the guinea pig in the Maximization Test under the test conditions chosen.
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Principles of method if other than guideline:
- The study was conducted according to the method described by Klecak (1977) and Klecak and Geleick (1977):
Klecak (1977), Dermatoxicology and Pharmacology. Eds, Marzulli F N, Maibach H I. New York: John Wiley & Sons.
Klecak and Geleick (1977), Journal of the Society of Cosmetic Chemists, 28: 53.
Freund's complete adjuvant test (FCAT): The guinea pigs were intradermally injected with 0.5 M of test substance in FCA and distilled water 5 times (day 0-9). On day 21 (challenge) and day 35 (rechallenge), the flank of the animals was treated epicutaneously in an open manner with different test substance concentrations including the highest non-irritant concentration and the skin reaction was observed 24 and 48 h after each application. - GLP compliance:
- not specified
- Type of study:
- Freund's complete adjuvant test
- Justification for non-LLNA method:
- The Freund's complete adjuvant test has been carried out as an animal test to predict human sensitization. The reliable study data would not justify conducting an additional LLNA due to animal welfare.
- Specific details on test material used for the study:
- - Source: Polyscience Inc., Warrington, USA
- Purity: > 99% - Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Olac Ltd., Bicester, GB
- Weight at study initiation: 350 - 450 g
- Housing: in pairs
- Diet (e.g. ad libitum): pellet diet containing vitamin C - Route:
- intradermal
- Vehicle:
- other: Freund´s Complete Adjuvant and distilled water
- Concentration / amount:
- 0.5 M/ 0.1 mL
- Day(s)/duration:
- days 0, 2, 4, 7, 9
- Adequacy of induction:
- not specified
- No.:
- #1
- Route:
- epicutaneous, open
- Vehicle:
- other: Freund´s Complete Adjuvant and distilled water
- Concentration / amount:
- highest non-irritant concentration and 2 lower concentrations (not further specified)/ 0.025 mL
- Day(s)/duration:
- day 21
- Adequacy of challenge:
- highest non-irritant concentration
- No.:
- #2
- Route:
- epicutaneous, open
- Vehicle:
- other: Freund´s Complete Adjuvant and distilled water
- Concentration / amount:
- highest non-irritant concentration and 2 lower concentrations (not further specified)/ 0.025 mL
- Day(s)/duration:
- day 35
- Adequacy of challenge:
- highest non-irritant concentration
- No. of animals per dose:
- 8 (experimental group), 4-6 (control)
- Details on study design:
- MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 5 times 0.1 mL on day 0, 2, 4, 7 and 9
B. CHALLENGE EXPOSURE
- No. of exposures: 2
- Day(s) of challenge: day 21 and day 35
- Evaluation (hr after challenge): readings after 24 and 48 h
other: The maximum non-irritant concentration was determined in a pre-test. The used vehicle was Aramek (oleum arachidis/methylethylketone). Progressively dilutions of the test material were investigated after 24 and 48 h after single open application the clipped flank of 8 animals. - Challenge controls:
- 4-6 animals
- Positive control substance(s):
- no
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- highest non-irritant concentration and 2 lower concentrations (not further specified)/ 0.025 mL
- No. with + reactions:
- 0
- Total no. in group:
- 8
- Clinical observations:
- no data
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- highest non-irritant concentration and 2 lower concentrations (not further specified)/ 0.025 mL
- No. with + reactions:
- 0
- Total no. in group:
- 8
- Clinical observations:
- no data
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- rechallenge
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- highest non-irritant concentration and 2 lower concentrations (not further specified)/ 0.025 mL
- No. with + reactions:
- 0
- Total no. in group:
- 8
- Clinical observations:
- no data
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- rechallenge
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- highest non-irritant concentration and 2 lower concentrations (not further specified)/ 0.025 mL
- No. with + reactions:
- 0
- Total no. in group:
- 8
- Clinical observations:
- no data
- Remarks on result:
- no indication of skin sensitisation
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The test substance was not sensitizing under the conditions of the present study in guinea pigs.
- Executive summary:
A publication is available which asesses the potential of the test substance to induce delayed contact hypersensitivity was assessed using the Freund's complete adjuvant test (FCAT), in a non-GLP study.
The concentrations of the test substance suitable for use in the main experiment were determined in a pretest. The minimum irritant concentration was determined in FCA pretreated animals. The maximum non-irritant concentration also was determined. The used vehicle in the pre-test was Aramek (oleum arachidis/methylethylketone). The guinea pigs were intradermally injected with 0.5 M of test substance in FCA and distilled water 5 times (day 0-9). On day 21 (challenge) and day 35 (rechallenge), the flank of the animals was treated epicutaneously in an open manner with different test substance concentrations including the highest non-irritant concentration and the skin reaction was observed 24 and 48 h after each application. The FCAT was carried out with 8 animals which showed no sensitising effects (0/8 animals) in the challenge and rechallenge.
Based on the results of this study it was concluded that the test material does not have a sensitizing effect on the skin of the guinea pig in the Maximization Test under the test conditions chosen.
Referenceopen allclose all
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
A publication is available which asesses the potential of the test substance to induce delayed contact hypersensitivity using the guinea pig maximization test (GPMT) based on the method of Magnusson and Kligman and in the Freund's complete adjuvant test (FCAT), both in a non-GLP conform study with a reliability of 2 (van der Walle et al., 1982).
The concentrations of the test substance suitable for use in the main experiment were determined in a pretest. The minimum irritant concentration was determined in FCA pretreated animals. The maximum non-irritant concentration also was determined. The used vehicle in the pre-test was Aramek (oleum arachidis/methylethylketone). For the intradermal induction in the GPMT 3 pairs of injections were set on the clipped shoulder region on day 0. One injection was with FCA alone, the second injection was the test material (0.5 M) in vehicle (peanut oil), the third injection was the test material (0.5 M) in FCA. On day 7, an epicutaneous induction with 1 M test material in the vehicle (80% ethanol) (the concentration giving a slight to moderate irritation) was performed on the same shoulder region. The challenge was performed on day 21 (epicutaneous, occlusive) and day 35 (epicutaneous, open) thereafter. The highest concentration tested was the maximum non-irritating concentration. In addition two lower concentrations and the vehicle were tested. The results were graded according to the classification of Magnusson & Kligman. Both challenges exhibited no positive reactions (0/10 animals).
In the FACT, the guinea pigs were intradermally injected with 0.5 M of test substance in FCA and distilled water 5 times (day 0-9). On day 21 (challenge) and day 35 (rechallenge), the flank of the animals was treated epicutaneously in an open manner with different test substance concentrations including the highest non-irritant concentration and the skin reaction was observed 24 and 48 h after each application. The FCAT was carried out with 8 animals which showed no sensitising effects (0/8 animals) in the challenge and rechallenge.
Based on the results of the above mentioned studies it was concluded that the test substance does not have a sensitizing effect on the skin of the guinea pig under the test conditions chosen in both studies.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
The available experimental test data are reliable and suitable for classification purposes under Regulation 1272/2008. No local reactions were observed in a guinea pig maximization test and Freund's complete adjuvant test. Therefore, the substance does not require classification as a skin sensitizer under Regulation (EC) No. 1272/2008, as amended for the fourteenth time in Regulation (EC) No. 2020/217.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
